EGFR delE709_T710insD: a rare but potentially EGFR inhibitor responsive mutation in non-small-cell lung cancer

समान संसाधन

• Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report
  द्वारा: An, Ning, और अन्य
  प्रकाशित: (2019)
• BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
  द्वारा: Kobayashi, Susumu, और अन्य
  प्रकाशित: (2013)
• Whacking a mole-cule: clinical activity and mechanisms of resistance to third generation EGFR inhibitors in EGFR mutated lung cancers with EGFR-T790M
  द्वारा: Costa, Daniel B., और अन्य
  प्रकाशित: (2015)
• Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations
  द्वारा: Vasconcelos, Pedro E.N.S., और अन्य
  प्रकाशित: (2020)
• EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
  द्वारा: Vasconcelos, Pedro E.N.S., और अन्य
  प्रकाशित: (2020)